Cargando…
Modeling of prolactin response following dopamine D(2) receptor antagonists in rats: can it be translated to clinical dosing?
Prolactin release is a side effect of antipsychotic therapy with dopamine antagonists, observed in rats as well as humans. We examined whether two semimechanistic models could describe prolactin response in rats and subsequently be translated to predict pituitary dopamine D(2) receptor occupancy and...
Autores principales: | Taneja, Amit, Vermeulen, An, Huntjens, Dymphy R. H., Danhof, Meindert, De Lange, Elizabeth C. M., Proost, Johannes H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723698/ https://www.ncbi.nlm.nih.gov/pubmed/29226628 http://dx.doi.org/10.1002/prp2.364 |
Ejemplares similares
-
Summary data of potency and parameter information from semi-mechanistic PKPD modeling of prolactin release following administration of the dopamine D(2) receptor antagonists risperidone, paliperidone and remoxipride in rats
por: Taneja, Amit, et al.
Publicado: (2016) -
In vitro and in silico analysis of the effects of D
(2) receptor antagonist target binding kinetics on the cellular response to fluctuating dopamine concentrations
por: de Witte, Wilhelmus E A, et al.
Publicado: (2018) -
Erratum to: Translational Modeling in Schizophrenia: Predicting Human Dopamine D(2) Receptor Occupancy
por: Johnson, Martin, et al.
Publicado: (2016) -
Mechanism-Based Pharmacokinetic–Pharmacodynamic Modeling of the Dopamine D(2) Receptor Occupancy of Olanzapine in Rats
por: Johnson, Martin, et al.
Publicado: (2011) -
Predicting Drug Concentration‐Time Profiles in Multiple CNS Compartments Using a Comprehensive Physiologically‐Based Pharmacokinetic Model
por: Yamamoto, Yumi, et al.
Publicado: (2017)